🇺🇸 FDA
Pipeline program

FX301

FX301-2020-001

Phase 1 small_molecule completed

Quick answer

FX301 for Pain, Postoperative is a Phase 1 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Pain, Postoperative
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials